Department of Immunology and Oncology, Spanish National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
INSERM U932, Institut Curie, PSL Research University, Paris, France.
Methods Mol Biol. 2021;2265:323-344. doi: 10.1007/978-1-0716-1205-7_24.
Most human cells release extracellular vesicles (EVs) of different sizes and composition, containing biomolecules characteristic from the originating tissue. In consequence, when EVs derive from a cancer cell, they also contain tumor antigens. Therefore, isolating and characterizing tumor-derived EVs has attracted great interest as an invaluable source of biomarkers, both for diagnosis and stratification of cancer. In this chapter, we describe a method for flow cytometry assessment of melanoma-derived EVs which are firstly captured onto antibody-coated beads recognizing either a common EV marker, namely, a tetraspanin, or a tumor antigen like the stress-related molecules MICA or PDL1. Then, after staining with a fluorophore-conjugated antibody directed against a different protein present on the EV surface, the EV-bead complex can be visualized in a conventional flow cytometer. The technique allows detection of proteins present on EVs isolated from tissue culture supernatants of melanoma cell lines and, more importantly, directly from plasma.
大多数人体细胞会释放出不同大小和组成的细胞外囊泡(EVs),其中包含源自其起源组织的生物分子。因此,当 EVs 来源于癌细胞时,它们也包含肿瘤抗原。因此,分离和表征源自肿瘤的 EVs 已成为一种极具吸引力的生物标志物来源,可用于癌症的诊断和分层。在本章中,我们描述了一种使用流式细胞术评估黑色素瘤衍生 EVs 的方法,该方法首先将抗体包被的珠子捕获到识别共同 EV 标志物(即四跨膜蛋白)或肿瘤抗原(如应激相关分子 MICA 或 PDL1)的抗体上。然后,在用针对 EV 表面上存在的另一种蛋白质的荧光标记抗体染色后,可以在常规流式细胞仪中观察到 EV-珠复合物。该技术可检测从黑色素瘤细胞系的组织培养上清液中分离出的 EVs 上存在的蛋白质,更重要的是,可直接从血浆中检测到。